Dihydroartemisinin was converted to its corresponding alkyne-functionalized esters, which were subsequently deployed as substrates for a ‘click’ chemistry-mediated coupling with 3′-azido-3′-deoxythydimine (AZT) to furnish novel triazole–artesunate–AZT hybrid compounds. Moreover, various substituted triazole–artemisinin hybrids were synthesized based on ‘click’ chemistry between propargyl-substituted derivatives and artemisinin containing a 2-hydroxypropane unit. Fourteen new hybrids were thus successfully prepared and evaluated as cytotoxic agents, revealing an interesting anticancer activity of four triazole–artemisinin derivative hybrids in KB and HepG2 cancer cell lines.
(a) LinA.J., KlaymanD.L., MilhousW.K. (1987) Antimalarial activity of new water-soluble dihydroartemisinin derivatives. Journal of Medicinal Chemistry, 30, 2147–2150; (b) Brossi A, Venugopalan B, Gerpe LD, Yeh HJC, Flippenanderson JL, Buchs P, Luo XD, Milhous W, Peters W. (1988) Arteether, a new antimalarial drug: synthesis and antimalarial properties. Journal of Medicinal Chemistry, 31, 645–650; (c) Tuyen NV, Vu TK, Sung TV, Cuong PV, Mai VT. (2002) Discovery of the antimalarial activity of new derivatives of artemisinin. Vietnamese Journal of Chemistry, 40, 124–126; (d) Tran Khac V, Nguyen Van T, Tran Van S. (2005) Synthesis of novel 10-deoxoartemisinins. Bioorganic & Medicinal Chemistry Letters, 15, 2629–2631; (e) White N. (2008) Qinghaosu (artemisinin): the price of success. Science, 320, 330–334; (f) Slack RD, Jacobine AM, Posner GH (2012) Antimalarial peroxides: advances in drug discovery and design. MedChemComm, 3, 281–297; (g) Wang N, Wicht KJ, Shaban E, Ngoc TA, Wang MQ, Hayashi I, Hossain MI, Takemasa Y, Kaiser M, El-Sayed IET, Egan TJ, Inokuchi T. (2014) Synthesis and evaluation of artesunate–indoloquinoline hybrids as antimalarial drug candidates MedChemComm, 5, 927–931; (h) Mazzone J, Conyers RC, Tripathi AK, Sullivan DJ, Posner GH. (2014) Antimalarial chemotherapy: Artemisinin-derived dimer carbonates and thiocarbonates. Bioorganic & Medicinal Chemistry Letters, 24, 2440–2443.
2.
(a) MichaelisM., KleinschmidtM.C., BarthS., RothweilerF., GeilerJ., BreitlingR., MayerB., DeubzerH., WittO., KreuterJ., DoerrH.W., CinatlJ., CinatlJrJ. (2010) Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochemical Pharmacology, 79, 130–136; (b) Lai H, Singh NP, Sasaki T. (2013) Development of artemisinin compounds for cancer treatment. Investigational New Drugs, 31, 230–246.
3.
GalalA.M., RossS.A., JacobM., ElSohlyM.A. (2005) Antifungal activity of artemisinin derivatives. Journal of Natural Product, 68, 1274–1276.
4.
(a) KrishnaS., BustamanteL., HaynesR.K., StainesH.M. (2008) Artemisinins: their growing importance in medicine. Trends in Pharmacological Sciences, 29, 520–527; (b) Aminake MN, Mahajan A, Kumar V, Hans R, Wiesner L, Taylor D, Kock C, Grobler A, Smith PJ, Kirschner M, Rethwilm A, Pradel G, Chibale K. (2012) Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy. Bioorganic Medicinal Chemistry, 20, 5277–5289.
5.
ZhouF.W., LeiH.S., FanL., JiangL., LiuJ., PengX.M., XuX.R., ChenL., ZhouC.H., ZouY.Y., LiuC.P., HeZ.Q., YangD.C. (2014) Design, synthesis, and biological evaluation of dihydroartemisinin–fluoroquinolone conjugates as a novel type of potential antitubercular agents. Bioorganic Medicinal Chemistry Letters, 24, 1912–1917.
6.
LeeS. (2007) Artemisinin, promising lead natural product for various drug developments. Mini-Reviews in Medicinal Chemistry, 7, 411–412.
7.
(a) ChoS., OhS., UmY., JungJ.H., HamJ., ShinW.S., LeeS. (2009) Synthesis of 10-substituted triazolyl artemisinins possessing anticancer activity via Huisgen 1,3-dipolar cycloaddition. Bioorganic Medicinal Chemistry Letters, 19, 382–385; (b) Oh S, Shin WS, Ham J, Lee S. (2010) Acid-catalyzed synthesis of 10-substituted triazolyl artemisinins and their growth inhibitory activity against various cancer cells. Bioorganic Medicinal Chemistry Letters, 20, 4112–4115; (c) Lee S. (2011) Synthesis of 10β-substituted triazolyl artemisinins and their growth inhibitory activity against various cancer cells. Bulletin of the Korean Chemical Society, 32, 737–741; (d) Saikia B, Saikia PP, Goswami A, Barua NC, Saxena AK, Suri N. (2011) Synthesis of a novel series of 1,2,3-triazole-containing artemisinin dimers with potent anticancer activity involving Huisgen 1,3-dipolar cycloaddition reaction. Synthesis, 19, 3173–3179; (e) Liu Y, Liu Z, Shi J, Chen H, Mi B, Li P, Gong P. (2013) Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups. Molecules, 18, 2864–2877; (f) Njogu PM, Gut J, Rosenthal PJ, Chibale K. (2013) Design, synthesis, and antiplasmodial activity of hybrid compounds based on (2R,3S)-N-benzoyl-3-phenylisoserine. ACS Medicinal Chemistry Letters, 2013, 4, 637–641; (g) Joubert JP, Smit FJ, Plessis LD, Smith PJ, N'Da DD. (2014) Synthesis and in vitro biological evaluation of aminoacridines and artemisinin-acridine hybrids. European Journal of Pharmaceutical Sciences, 56, 16–27; (h) Bertinaria M, Orjuela-Sanchez P, Marini E, Guglielmo S, Hofer A, Martins YC, Zanini GM, Frangos JA, Gasco A, Fruttero R, Carvalho LJM. (2015) NO-donor dihydroartemisinin derivatives as multitarget agents for the treatment of cerebral malaria. Journal of Medicinal Chemistry, 58, 7895–7899; (i) Le HB, Nguyen TTV, Vu TK, Nguyen TTM, Luu VC, Nguyen TN, Hoang XT, Do TT, Tran KV. (2016) Synthesis and in vitro cytotoxic evaluation of new triazole derivatives based on artemisinin via click chemistry. Medicinal Chemistry Research, 1–13; (j) Xu CC, Deng T, Fan ML, Lv WB, Liu JH, Yu BY. (2016) Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives. European Journal of Medicinal Chemistry, 107, 192–203.
8.
(a) AndreuccettiM., AllegriniG., AntonuzzoA., MalvaldiG., ConteP.F., DanesiR., Del TaccaM., FalconeA. (1996) Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: In vitro synergistic cytotoxicity and DNA-induced strand-breaks. European Journal of Cancer, 32, 1219–1226; (b) Johnston JS, Johnson A, Gan Y, Wientjes MG, Au JL. (2003) Synergy between 3′azido-3′deoxythymidine and paclitaxel in human pharynx fadu cells. Pharmaceutical Research, 20, 957–961; (c) Mattson DM, Ahmad IM, Dayal D, Parsons AD, Aykin-Burns N, Li L, Orcutt KP, Spitz DR, Dornfeld KJ, Simons AL. (2009) Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radical Biology and Medicine, 46, 232–237; (d) Dang Thi TA, Kim Tuyet NT, Pham The C, Nguyen HT, Ba Thi C, Doan Duy T, D'hooghe M, Van Nguyen T. (2014) Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid–AZT conjugates. Bioorganic Medicinal Chemistry Letters, 24, 5190–5194; (e) Dang Thi TA, Kim Tuyet NT, Pham The C, Nguyen HT, Ba Thi C, Phuong HT, Boi LT, Van Nguyen T, D'hooghe M. (2015) Synthesis and cytotoxic evaluation of novel amide–triazole-linked triterpenoid–AZT conjugates. Tetrahedron Letters, 56, 218–224; (f) Pham Thi T, Le Nhat TG, Ngo Hanh T, Luc Quang T, Pham The C, Dang Thi TA, Nguyen HT, Nguyen TH, Hoang Thi P, Van Nguyen T. (2016) Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids. Bioorganic Medicinal Chemistry Letters, 26, 3652–3657.
9.
(a) ZhouC., PanW., WangX.P., ChenT.S. (2012) Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells. Journal of Cellular Physiology, 227, 3778–3786; (b) Zhao YY, Jiang WW, Li B, Yao Q, Dong JQ, Cen YY, Pan XC, Li J, Zheng J, Pang XL, Zhou H. (2011) Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase. International Immunopharmacology, 11, 2039–2046.
10.
BockV.D., HiemstraH., MaarseveenJ.H. (2006) CuI-catalyzed alkyne–azide “click” cycloadditions from a mechanistic and synthetic perspective. European Journal of Organic Chemistry, 1, 51–68.